Windlas Biotech Limited (NSE:WINDLAS)

Windlas Biotech Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	23.11	5.35	4.24	52.88	36.86	5.7
Short-Term Investments	2,599	99.13	154.81	256.39	217.68	1,106
Trading Asset Securities	-	2,684	2,234	1,734	1,065	648.24
Cash & Short-Term Investments	2,622	2,788	2,393	2,044	1,320	1,760
Cash Growth	0.64%	16.53%	17.08%	54.86%	-25.03%	224.44%
Accounts Receivable	2,886	2,274	1,669	1,363	1,169	1,108
Other Receivables	-	4.3	38.64	6.66	4.38	22.13
Receivables	2,886	2,278	1,707	1,369	1,173	1,130
Inventory	1,133	618.24	813.84	621.89	747.38	587.1
Prepaid Expenses	-	13.94	10.54	9.84	8.71	9.54
Other Current Assets	624.51	569.83	329.88	268.08	286.61	329.76
Total Current Assets	7,267	6,269	5,254	4,313	3,535	3,817
Property, Plant & Equipment	2,740	2,660	2,219	1,803	1,227	983.15
Long-Term Investments	-	-	0.5	16.38	52.44	25.61
Other Intangible Assets	57.14	69.11	67.79	44.68	14.84	8.82
Long-Term Deferred Tax Assets	13.47	4.48	2.83	5.72	20.25	20.35
Other Long-Term Assets	76.07	71.32	59.84	79.54	439.85	55.67
Total Assets	10,153	9,073	7,605	6,262	5,290	4,910

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	3,187	2,385	1,778	1,315	877.43	632.32
Accrued Expenses	33.69	369.94	284.71	336.36	282.13	228.55
Short-Term Debt	-	-	-	-	-	53.13
Current Portion of Long-Term Debt	462.38	298.75	271.17	1.09	3.35	3.64
Current Portion of Leases	34.25	32.19	32.29	15.14	15.32	5.16
Current Income Taxes Payable	55.59	22.92	-	-	5.91	-
Other Current Liabilities	611.63	100.57	127.87	49.81	28.28	17.06
Total Current Liabilities	4,384	3,209	2,494	1,718	1,212	939.86
Long-Term Debt	-	-	-	-	1.09	4.44
Long-Term Leases	37.66	21.48	22.51	20.18	30.17	-
Other Long-Term Liabilities	40.43	34.32	29.84	25.01	23.36	18.03
Total Liabilities	4,462	3,265	2,547	1,763	1,267	962.33

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	103.18	105.53	104.8	103.99	104.63	108.97
Additional Paid-In Capital	-	2,029	1,989	1,946	1,986	2,269
Retained Earnings	-	3,473	2,907	2,396	1,900	1,551
Comprehensive Income & Other	5,588	201.14	56.99	53.45	32.19	18.04
Total Common Equity	5,691	5,808	5,058	4,499	4,023	3,948
Shareholders' Equity	5,691	5,808	5,058	4,499	4,023	3,948
Total Liabilities & Equity	10,153	9,073	7,605	6,262	5,290	4,910

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	534.29	352.42	325.97	36.41	49.93	66.37
Net Cash (Debt)	2,088	2,436	2,067	2,007	1,270	1,694
Net Cash Growth	-8.96%	17.85%	2.97%	58.08%	-25.04%	673.25%
Net Cash Per Share	97.90	114.17	97.82	96.16	58.69	82.64
Filing Date Shares Outstanding	20.63	20.64	20.96	20.8	20.95	21.79
Total Common Shares Outstanding	20.63	21.11	20.96	20.8	20.95	21.79
Working Capital	2,882	3,059	2,760	2,595	2,323	2,877
Book Value Per Share	275.85	275.20	241.31	216.33	192.05	181.14
Tangible Book Value	5,634	5,739	4,990	4,455	4,008	3,939
Tangible Book Value Per Share	273.08	271.92	238.08	214.18	191.34	180.73
Land	-	313.59	313.59	313.59	313.59	215.71
Buildings	-	811.97	807.45	637.58	489.59	453.6
Machinery	-	2,150	1,970	1,639	1,005	890.46
Construction In Progress	-	561.55	32.01	57.08	138.01	75.81

Data Source: S&P Global Market Intelligence Last updated: Nov 5, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 11, 2026

Data Sources Report a data error